Correlation Between NLS Pharmaceutics and GeoVax Labs

Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and GeoVax Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and GeoVax Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NLS Pharmaceutics AG and GeoVax Labs, you can compare the effects of market volatilities on NLS Pharmaceutics and GeoVax Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of GeoVax Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and GeoVax Labs.

Diversification Opportunities for NLS Pharmaceutics and GeoVax Labs

0.16

Correlation Coefficient

NLS Pharmaceutics  GeoVax Labs

Average diversification

The 3 months correlation between NLS and GeoVax is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and GeoVax Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeoVax Labs and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with GeoVax Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeoVax Labs has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and GeoVax Labs go up and down completely randomly.

Pair Corralation between NLS Pharmaceutics and GeoVax Labs

Assuming the 90 days horizon NLS Pharmaceutics is expected to generate 1.41 times less return on investment than GeoVax Labs. But when comparing it to its historical volatility, NLS Pharmaceutics AG is 1.07 times less risky than GeoVax Labs. It trades about 0.08 of its potential returns per unit of risk. GeoVax Labs is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  15.00  in GeoVax Labs on September 16, 2024 and sell it today you would lose (4.00) from holding GeoVax Labs or give up 26.67% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	76.21%
Values	Daily Returns

NLS Pharmaceutics AG  vs.  GeoVax Labs

NLS Pharmaceutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NLS Pharmaceutics AG are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, NLS Pharmaceutics showed solid returns over the last few months and may actually be approaching a breakup point.

GeoVax Labs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeoVax Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with NLS Pharmaceutics and GeoVax Labs

The main advantage of trading using opposite NLS Pharmaceutics and GeoVax Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, GeoVax Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeoVax Labs will offset losses from the drop in GeoVax Labs' long position.

The idea behind NLS Pharmaceutics AG and GeoVax Labs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.